Hepatology Clinical Development Lead

GlaxoSmithKline; Upper Providence (Delaware County); Hybrid; USD 202,500 - 371,250; Full time

Job summary

GlaxoSmithKline seeks an experienced Medical Director for Clinical Development - Hepatology to lead clinical development plans, target validation and translational programs within RIIRU. The role emphasizes medical governance, safety oversight and cross-functional leadership across disciplines.

You will collaborate with regulatory, scientific and clinical teams to shape development plans, drive milestones, and ensure robust evidence generation while aligning with patient needs and enterprise

Qualifications

• Medical degree and postgraduate clinical training with demonstrated experience in clinical trial conduct.
• Strong knowledge of GCP, ICH guidelines, and global regulatory frameworks.
• Ability to apply clinical judgment to support study design, patient safety, and decision-making.

Responsibilities

• Provide medical monitoring and oversight of study safety; contribute to regulatory interactions and documentation.
• Lead the Clinical Matrix Team and drive end-to-end clinical development strategy for programs.
• Develop and deliver CDPs, including study timelines, endpoints, and translational components.
• Collaborate with cross-functional teams to integrate scientific, clinical, regulatory and commercial inputs.
• Demonstrate influential leadership within a matrix organization and manage stakeholder expectations.

Skills

Clinical trial conduct

Regulatory understanding

Medical judgment

Leadership

Education

Medical degree

Postgraduate clinical training / residency

Tools

GCP/ICH knowledge

Regulatory submissions experience

Job description

GlaxoSmithKline seeks an experienced Medical Director for Clinical Development - Hepatology to lead clinical development plans, target validation and translational programs within RIIRU. The role emphasizes medical governance, safety oversight and cross-functional leadership across disciplines.

You will collaborate with regulatory, scientific and clinical teams to shape development plans, drive milestones, and ensure robust evidence generation while aligning with patient needs and enterprise